HealthyGIBSNCT07633652
Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II ( GIBS)
A study testing SKIN test, MOVE and water load test II in people with Healthy, run by Centre Hospitalier Metropole Savoie at 1 site in France.
Trial summary
The aim of this study was to evaluate whether gastric interoceptive information has a direct impact on the motor and tactile dimensions of the body schema. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- SKIN test, MOVE and water load test II
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 108 participants
- Where
- 1 siteFrance
- Study dates
- 4 Feb 2025to 2 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy Volunteers without pathology
Who cannot join
- pregnant,
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II
The aim of this study was to evaluate whether gastric interoceptive information has a direct impact on the motor and tactile dimensions of the body schema.
- Conditions
- Healthy
- Being tested
- SKIN test, MOVE, water load test II, Water load test questionnary
- Keywords
- body schema, water load test II, gastric interoceptive signals
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SKIN testOther
SKIN test
MOVEOther
test MOVE
water load test IIOther
water load test II
Water load test questionnaryOther
Water load test questionnary
| Study group | Role | What they receive |
|---|---|---|
| body schema during waterload test II | Experimental | waterload test II Receives: Other: SKIN test; Other: MOVE; Other: water load test II; Other: Water load test questionnary |
What is being measured
The primary outcome is the main question the study is designed to answer.
modification of the body schema in its motor and tactile dimensions
The primary endpoint is composite and corresponds to the two differences in SKIN and MOVE scores, measured before and after the gastric interoceptive activation task, which assess the integrity of the body pattern.
- The SKIN score is the average difference (in mm) between the actual deviation applied to the shoulder and belly skin and the estimated deviation reported by the participant.
- MOVE score is the average ratio between the minimum distance (in mm) between virtual balls thrown at a person's shoulders and belly and from which they are avoided, and the actual morphology of this person at the point where the bullets pass (actual body width in mm).
Measured: before and within 10 minutes after gastric interoceptive activation task (day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jun 2026
- Study start4 Feb 2025
- Primary completion2 Oct 2025
- Study completion2 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 108 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Metropole Savoie
- Sponsor type
- University, hospital or other
- Collaborators
- University Savoie Mont-Blanc
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07633652
- Sponsor's protocol ID
- 2024-A01370-47
- Acronym
- GIBS
- Status last verified
- Oct 2026
- First submitted
- 4 Apr 2025
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II
- ClinicalTrials.gov ID
- NCT07633652
- Acronym / sponsor ID
- GIBS / 2024-A01370-47
- Conditions
- Healthy
- Keywords
- body schema, water load test II, gastric interoceptive signals
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 108 participants (actual)
- Lead sponsor
- Centre Hospitalier Metropole SavoieUniversity, hospital or other
- Collaborators
- University Savoie Mont-Blanc
- Study start
- 4 Feb 2025 (actual)
- Primary completion
- 2 Oct 2025 (actual)
- Study completion
- 2 Oct 2025 (actual)
- First posted
- 8 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to evaluate whether gastric interoceptive information has a direct impact on the motor and tactile dimensions of the body schema.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| body schema during waterload test II | Experimental | Other: SKIN test, Other: MOVE, Other: water load test II, Other: Water load test questionnarywaterload test II |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Healthy Volunteers without pathology
Key exclusion criteria (1 listed)
- pregnant,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SKIN testSKIN test | Other | body schema during waterload test II |
| MOVEtest MOVE | Other | body schema during waterload test II |
| water load test IIwater load test II | Other | body schema during waterload test II |
| Water load test questionnaryWater load test questionnary | Other | body schema during waterload test II |
Primary outcome
modification of the body schema in its motor and tactile dimensions
Time frame: before and within 10 minutes after gastric interoceptive activation task (day 1)
The primary endpoint is composite and corresponds to the two differences in SKIN and MOVE scores, measured before and after the gastric interoceptive activation task, which assess the integrity of the body pattern. * The SKIN score is the average difference (in mm) between the actual deviation applied to the shoulder and belly skin and the estimated deviation reported by the participant. * MOVE score is the average ratio between the minimum distance (in mm) between virtual balls thrown at a person's shoulders and belly and from which they are avoided, and the actual morphology of this person at the point where the bullets pass (actual body width in mm).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SKIN test, MOVE and water load test II in people with Healthy, run by Centre Hospitalier Metropole Savoie at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
modification of the body schema in its motor and tactile dimensions (time frame: before and within 10 minutes after gastric interoceptive activation task (day 1)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.